HUTCHMED (China) Limited Profit Margin

The latest profit margin for HCM is 3.26% as of June 2026. That compares with 77.53% in the prior-year period — down 95.8% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside HUTCHMED (China) Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, HCM's profit margin moved from 77.53% to 3.26% — a 95.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in HUTCHMED (China) Limited's valuation or profitability profile.

Against Healthcare companies, HCM currently prints 3.26% for profit margin, while the sector average sits near 21.34%. That is roughly 84.7% below the sector mean. Large gaps often invite a closer look at HUTCHMED (China) Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively HUTCHMED (China) Limited converts resources into returns. At 3.26%, HCM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 77.53% in the prior-year period — down 95.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting HCM's profit margin (3.26%), review year-over-year change from 77.53%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.